Supplies
Ended Awarded Last action
- Contract number
- 75N91024F00002
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,443
Award facts
- Contract value 100% obligated
- $20,442.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98119, USA
Award details come from SAM.gov/FPDS.
About this award
Nanostring Technologies, Inc. received a $20,442.50 firm fixed-price blanket purchase agreement (BPA) call from the National Cancer Institute on April 12, 2024, with completion scheduled for July 12, 2024. This supplies contract, which carries no set-aside designation, represents a task order under an existing BPA vehicle and will be performed in Seattle, Washington. The award supports the National Cancer Institute's research mission by providing specialized genomic analysis products or services from Nanostring's portfolio, which includes advanced platforms such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler used for multiplexed detection and analysis of nucleic acids, proteins, and cells in biomedical research applications.
Nanostring Technologies is a publicly traded provider of genomic analysis platforms and life science tools with an established history of federal contracting across multiple agencies including the NIH, Department of Veterans Affairs, Department of Defense, and USDA. The company currently holds two significant federal contract vehicles, including a $2.8 million blanket purchase agreement with the Defense Health Agency through August 2026 and a $596,881.45 indefinite delivery/indefinite quantity contract with USDA through April 2028. This National Cancer Institute award represents continued engagement with the company's core competencies in providing genomic research solutions to support the federal government's cancer research and translational medicine initiatives.
Quick answers
Who was awarded contract 75N91024F00002?
75N91024F00002 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on April 12, 2024.
How much is contract 75N91024F00002 worth?
The government has obligated $20,443 on 75N91024F00002.
Is contract 75N91024F00002 an order under another contract?
Yes. 75N91024F00002 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract 75N91024F00002 competed?
The extent of competition for 75N91024F00002 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award